This Fund’s Picks Returned 52% In Q1 And You’ve Never Heard Of It

MiMedx Group Inc. (Nasdaq: MDXG)

MiMedx Group Inc. is another stock that had a decent first-quarter but an even better second-quarter. The stock is now up by 72% this year thanks to gargantuan gains of 60% over the last six-plus weeks. MiMedx Group Inc. shares started soaring in mid-April when the company preannounced some of its Q1 results, including revenue that beat estimates.

The market appears to finally be rewarding the company for its track record of strong revenue growth now that profitability is making big strides as well (operating income is projected to rise by as much as 90% this year). MiMedx has also diversified its portfolio away from just wound care treatments, which has eased concerns that its portfolio could be usurped by a competitor in one fell swoop. Craig-Hallum recently raised its price target on MiMedx to $19 from $15, suggesting there is still further room for the stock to run.

1 2 3
View single page >> |

Disclosure: None

How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.